A 29-year-old woman who is battling cancer is leading calls for a specialist treatment to be funded on the NHS.

Megan McClay, from Wymondham, was diagnosed with uveal melanoma in 2020 - a rare form of the disease that begins in the eye.

Ms McClay then later learned that the condition had caused tumours to spread to her liver.

Eastern Daily Press:

She said: "Upon learning that the cancer had spread to my liver, one of my biggest concerns was the availability of treatment options.

"Unfortunately my options are limited as I simply cannot afford chemosaturation.

"This is deeply troubling for myself, my family and for the many others in a similar situation."

Chemosaturation therapy - otherwise known as percutaneous hepatic perfusion (PHP) - is a form of treatment which allows high-dose chemotherapy to be applied to hepatic tumours.

According to national charity OcuMel UK, it has proven to be 90pc effective, with this success rate acknowledged by the National Institute for Health and Care Excellence.

However, it is currently not funded by the NHS.

Ms McClay added: "I am devastated that I will not be able to experience the hope this treatment brings.

"I, of course, have a strong desire to survive for as long as possible and it worries me that finances may prevent this from happening."

Neil Pearce, a retired consultant surgeon and chairman of OcuMel UK, said: "It is really devastating that patients with ocular melanoma that has spread to the liver are being denied access to a treatment proven to boost survival."

An NHS England spokesman said: "While Nice incorporated chemosaturation therapy into available treatment options, it specifically advised using it with caution.

"NHS England also identified there was insufficient evidence to make it routinely available and will look to review the evidence again later this year."